FRA:GP7
Delisted

Central Garden & Pet Company Stock Signals

etoro logo Buy GP7
*Your capital is at risk
37.80€
+0.400 (+1.07%)
At Close: Jan 30, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Central Garden & Pet Company

General

Signal Type Signal Value Data
Score 0.000 253 days ( 2.07 %
Last Price 37.80€ 1.07 %
Performance History
7 Days
37.20€ 37.80€
1.61%
30 Days
35.40€ 37.80€
6.78%
12 Mos
40.40€ 37.80€
-6.44%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 50
Signal Type Signal Value Importance Data
High / Low N/A Very Low 37.80€ - 37.80€
Trend - 3 mos -16.06 % High Width: 23.24 %
Pred. range - 3 mos 25.85€ - 31.86€ Low -31.61 % - -15.72 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 25, 2023 - 4 days
RSI Short Pivot Signal Buy Very Low Jan 27, 2023 - 2 days
Short MA 3 mos Buy Low Jan 06, 2023 - 17 days
Long MA 3 mos Buy Medium Jan 13, 2023 - 12 days
Short/Long MA 3 mos Buy Medium Jan 17, 2023 - 10 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.89
Signal Type Signal Value Importance Data
Trend - 12 mos -9.45 % Very High Width: 26.41 %
Pred. range - 12 mos 30.50€ - 38.55€ High -19.31 % - 2.00 %
Short MA 12 mos Buy Very High Jan 06, 2023 - 17 days
Long MA 12 mos Sell Very High Nov 22, 2022 - 49 days
Short/Long MA 12 mos Sell Very High Nov 30, 2022 - 43 days
Pivot Long Sell Low Jan 24, 2023 - 5 days
RSI Long Pivot Signal Sell Low Jan 27, 2023 - 2 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CENTRAL GARDEN & PET COMPANY
Central Garden & Pet Company
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
OSIS
$218.29
0.188% Jun 26
IIIV
$20.09
6.32% Jun 25
JLL
$299.78
3.39% Jun 24
NMRK
$15.02
0.599% Jun 24
X
XMAX
$8.34
8.99% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE